Research and Development Tax Relief– Updated HMRC Guidance for Software & IT Projects
We’ve teamed up with Annette Beresford from Jurit LLP, who have recently been awarded ‘Most Pragmatic Legal Solutions Provide 2019’ in the UK Enterprise Awards, to write this article as we share a very...
Rheumatology drugs study
Researchers at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath, part of the Royal United Hospitals Bath NHS Foundation Trust, are celebrating recruiting the first patient globally to an international study that...
Moving healthcare forward
Making cutting edge treatments accessible to more patients, is one of the greatest challenges facing the healthcare system and biosimilars are playing a part in making this possible. In this issue, we speak to...
More than £700m saved
The NHS has saved more than £700 million from the annual medicines bill to reinvest in new treatments as part of the Long Term Plan.
An NHS-wide campaign has supported patients and doctors to maximise...
In the blink of an eye
Blinking an eye may seem a simple action, but in this issue, we learn how imperative it is for eye health. Professor James Wolffsohn, Chair of Optometry and associate pro-vice-chancellor of Aston University, casts...
Many layers to cancer research
Dr Gernot Walko, is a skin biologist and Lecturer in Stem Cell Biology at the University of Bath. In 2017, Dr Walko was awarded a British Skin Foundation small grant for his research, ‘Targeting...
A British Skin Foundation funded project into atopic eczema
Human beta-defensin in Atopic Dermatitis: dissecting the mechanism
of a novel, targetable, protection against skin barrier damage.
Dr Donald J. Davidson is an Inflammation Biologist and Senior Researcher at the University of Edinburgh Centre for Inflammation...
Patient recruitment: The balancing act
Well conducted patient and public engagement can have a positive impact on recruitment and retention. To really increase your chances of success you need to be engaging patients as early as possible in the...
Treading the path less travelled – A different approach to patient recruitment
In a previous issue, we spoke to Professor Miles Witham about his work to facilitate the participation of older people in clinical trials. Now we hear from Sarah Montague about a trial engaging homeless...
Compulsory licensing of pharmaceuticals: A solution to high drug prices?
The UK continues to grapple with its departure – or not – from the European Union, and whilst the outcome remains unclear, one thing now seems certain: before long there will be a general...
Why waste plastic bottles are a valuable resource
Dr Timothy Whitehead, Lecturer in Product Design for Low-Income Countries at Aston University, explains how we can add value to waste plastic bottles and how these can be turned into essential products for the...
The Open University – The higher education partner of choice for business
In April 1969, The Open University (OU) received its Royal Charter and the vision of a university that would open up education for all, was finally brought to life – largely due to the...
Bridging the gap between academic learning and on the job skills
The University of Salford’s Environment and Life Science degree apprenticeship programmes are a key area of development. The Biomedical Science degree apprenticeship programme has expanded rapidly over the past couple of years and the...
Life sciences is bucking the trend in providing Venture Capital for female founders
Alice Hu Wagner - Managing Director, Strategy, Economics and Business Development at British Business Bank
Life sciences is one of the most successful sectors in the UK economy and its continued growth is a key...
Plant patentability and the European Patent Office – what is the latest update?
Plant patentability has long been a contentious issue throughout intellectual property and scientific circles.
The question as to whether plants or animals created through essentially biological processes, such as genetic or selective breeding, can be...
Biosimilars and Patents
Leonita Paulraj - Associate, AA Thornton
The majority of the world’s biggest selling medicines can be classified as “biologics” or “biopharmaceuticals”. Such medicines contain one or more biologically active product produced from (or containing components of)...